Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy A M Berbers

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|October 26, 2013
Immune responses to pertussis vaccines and diseaseKathryn M Edwards, Guy A M Berbers
Clinical and Vaccine Immunology : CVI|February 5, 2010
Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccineKarin E M Elberse, Irina Tcherniaeva, Guy A M Berbers, et al.
Vaccine|December 5, 2017
Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccinationSaskia van der Lee, Elisabeth A M Sanders, Guy A M Berbers, et al.
Annals of the Rheumatic Diseases|December 17, 2011
Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional studyMarloes W Heijstek, Pieter G M van Gageldonk, Guy A M Berbers, et al.
Vaccine|May 21, 2018
Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccinesEmile F F Jonker, Mariëtte B van Ravenhorst, Guy A M Berbers, et al.
Protein Expression and Purification|April 2, 2005
The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coliMarcel Hijnen, Pieter G M van Gageldonk, Guy A M Berbers, et al.
Vaccine|September 9, 2017
Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adultsMarieke van der Heiden, Aafke Duizendstra, Guy A M Berbers, et al.
Vaccine|September 5, 2009
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen contentLotte H Hendrikx, Guy A M Berbers, Reinier H Veenhoven, et al.
Clinical and Vaccine Immunology : CVI|May 27, 2011
Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoidPieter G M van Gageldonk, Christina von Hunolstein, Fiona R M van der Klis, et al.
Scandinavian Journal of Infectious Diseases|October 11, 2007
Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactinMarcel Hijnen, Qiushui He, Rutger Schepp, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|October 26, 2013
Immune responses to pertussis vaccines and diseaseKathryn M Edwards, Guy A M Berbers
Clinical and Vaccine Immunology : CVI|February 5, 2010
Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccineKarin E M Elberse, Irina Tcherniaeva, Guy A M Berbers, et al.
Vaccine|December 5, 2017
Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccinationSaskia van der Lee, Elisabeth A M Sanders, Guy A M Berbers, et al.
Annals of the Rheumatic Diseases|December 17, 2011
Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional studyMarloes W Heijstek, Pieter G M van Gageldonk, Guy A M Berbers, et al.
Vaccine|May 21, 2018
Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccinesEmile F F Jonker, Mariëtte B van Ravenhorst, Guy A M Berbers, et al.
Protein Expression and Purification|April 2, 2005
The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coliMarcel Hijnen, Pieter G M van Gageldonk, Guy A M Berbers, et al.
Vaccine|September 9, 2017
Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adultsMarieke van der Heiden, Aafke Duizendstra, Guy A M Berbers, et al.
Vaccine|September 5, 2009
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen contentLotte H Hendrikx, Guy A M Berbers, Reinier H Veenhoven, et al.
Clinical and Vaccine Immunology : CVI|May 27, 2011
Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoidPieter G M van Gageldonk, Christina von Hunolstein, Fiona R M van der Klis, et al.
Scandinavian Journal of Infectious Diseases|October 11, 2007
Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactinMarcel Hijnen, Qiushui He, Rutger Schepp, et al.
Pageof 13